O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/20/2021ACC: 0001209191-21-004250
Officer· Chief Medical Officer
Since Jun 2018
+188.00
Net shares
Net buyer
$1.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
188.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+94.00
Price / share
$16.99
Trade value
$1.60K
% of position
3.0%
1/15/2021
3.17K→3.26K
Total
Net shares
+94.00
Net value
$1.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/15/2021 | A · Award | +94.00 | $16.99 | $1.60K | 3.0% | 3.17K | 3.26K |
| Total | +94.00 | $1.60K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
94.00 shares
Shares
+94.00
Strike price
19.99
Held after
94.00
Exercisable
—
1/15/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock94.00 shares | 1/15/2021 | A · Award | +94.00 | 19.99 | — | 94.00 |